Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: Secondary analysis of a randomized clinical trial

European Journal of Clinical Nutrition

Volumn 67, Issue 12, 2013, Pages 1291-1297

  Ma, X ^a   Gu, J ^a   Zhang, Z ^a   Jing, L ^a   Li, Y ^a   Xu, M ^a   Dai, X ^a   Jiang, Y ^a   Bao, L ^a   Cai, X ^a   Ding, Y ^a   Wang, J ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

cardiovascular disease; cereals; diabetes mellitus; Metabolic syndrome X; Type 2

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; LIPID;

ADULT; AGED; ARTICLE; AVENA; AVENA NUDA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CHINESE; CONTROLLED STUDY; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION EDUCATION; OAT; PARALLEL DESIGN; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TREATMENT OUTCOME;

AVENA NUDA;

AVENA SATIVA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84889590699     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.201     Document Type: Article

References (42)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362: 1090-1101
2. IDF. IDF Diabetes Atlas. 5th edn. International Diabetes Federation: Brussels, Belgium, 2011
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 1-20
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214 (Pubitemid 36523358)
5. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211 (Pubitemid 46684649)
6. Franz MJ, Powers MA, Leontos C, Holzmeister LA, Kulkarni K, Monk A et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults. J Am Diet Assoc 2010; 110: 1852-1889
7. Boucher JL, Evert A, Daly A, Kulkarni K, Rizzotto JA, Burton K et al. American Dietetic Association revised standards of practice and standards of professional performance for registered Dietitians (generalist, specialty, and advanced) in diabetes care. J Am Diet Assoc 2011; 111: 156-166
8. de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: A prospective cohort study and systematic review. PLoS Med 2007; 4: 1385-1395 (Pubitemid 47358174)
9. Sahyoun Nadine R, Jacques Paul F, Zhang Xinli L, Juan Wenyen, McKeown Nicola M. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 2006; 83: 124-131
10. Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain consumption and the metabolic syndrome: A favorable association in Tehranian adults. Eur J Clin Nutr 2005; 59: 353-362 (Pubitemid 40403288)
11. Katcher Heather I, Legro Richard S, Kunselman Allen R, Gillies Peter J, Demers Laurence M, Bagshaw Deborah M et al. The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 2008; 87: 79-90
12. U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010. Available at http://www.cnpp.usda.gov/ DGAs2010-PolicyDocument.html (accessed 16 December 2012
13. The Elderly Nutrition Branch of Chinese Nutrition Society. Dietary guidelines for elderly Chinese. Shandong, 2010
14. Masood SB, Muhammad TN, Muhammad KK, Rabia S, Mehmood SB. Oat: Unique among the cereals. Eur J Nutr 2008; 47: 68-79
15. Weickert MO, Möhlig M, Schöfl C, Arafat AM, Otto B, Viehoff H et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006; 29: 775-780 (Pubitemid 44115293)
16. Lammert A, Kratzsch J, Selhorst J, Humpert PM, Bierhaus A, Birck R et al. Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: A pilot study. Exp Clin Endocrinol Diabetes 2008; 116: 132-134 (Pubitemid 351363385)
17. Cugnet-Anceau C, Nazare JA, Biorklund M, Le Coquil E, Sassolas A, Sothier M et al. A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr 2010; 103: 422-428
18. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V et al. Physicochemical properties of oat b-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. Am J Clin Nutr 2010; 92: 723-732
19. Berg A, Konig D, Deibert P, Grathwohl D, Berg A, Baumstark MW et al. Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann Nutr Metab 2003; 47: 306-311 (Pubitemid 38253109)
20. Beck EJ, Tapsell LC, Batterham MJ, Tosh SM, Huang XF. Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr 2010; 103: 1212-1222
21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421
22. Institute of Nutrition and food safety. China CDC 2005 China Food Composition. Peking University Medical Press, 2004
23. Chinese Nutrition Society. Dietary Guidelines for Chinese Residents (2011). Tibet People's Publishing House: Lhasa, 2010
24. Chinese Diabetes Society. China Medical Nutrition Therapy Guideline for Diabetes 2010. Available at http://cdschina.org/news-show.jsp?id=509.html (accessed 16 December 2012
25. Shi H, Lian CL. The relationship between hypersensitive C-reactive protein and disorders of lipid metabolism in patients with Type 2 diabetes mellitus. Chin Med J Metall Indus 2011; 28: 29-30
26. Wen HH, Niu LJ. The relationship between serum adiponectin levels and insulin resistance in metabolic syndrome patients without diabetes. J Diseases Monitor Control 2012; 6: 65-67
27. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000; 23: 57-63
28. International Diabetes Federation. The IDF consensus worldwide definition of the MS 2006
29. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321: 405-412 (Pubitemid 30609442)
30. Kones Richard. Primary prevention of coronary heart disease:integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther 2011; 5: 325-380
31. Braaten JT, Scott FW, Wood PJ, Riedel KD, Wolynetz MS, Brulé D et al. High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 1994; 11: 312-318
32. Anderson JW, Hamilton CC, Horn JL, Spencer DB, Dillon DW, Zeigler JA. Metabolic effects of insoluble oat fiber on lean men with type II diabetes. Cereal Chem 1991; 68: 291-294
33. Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2005; 15: 255-261 (Pubitemid 41190982)
34. Jenkins AL, Jenkins DJ, Zdravkovic U, Wu? rsch P, Vuksan V. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr 2002; 56: 622-628 (Pubitemid 34822901)
35. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: A pilot study. J Am Diet Assoc 1996; 96: 1254-1261 (Pubitemid 27381748)
36. Othman RA, Moghadasian MH, Jones PJ. Cholesterol-lowering effects of oat b-glucan. Nutr Rev 2011; 69: 299-309
37. Chen J, He J, Wildman RP, Reynolds K, Streiffer RH, Whelton PK. A randomized controlled trial of dietary fiber intake on serum lipids. Eur J Clin Nutr 2006; 60: 62-68 (Pubitemid 43731076)
38. Biorklund M, Holm J, Onning G. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucancontaining ready meal. Ann Nutr Metab 2008; 52: 83-90 (Pubitemid 351723129)
39. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339: 12-20 (Pubitemid 28304492)
40. Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V et al. Physicochemical properties of oat b-glucan influence its ability to reduce serum LDL cholesterol in humans:a randomized clinical trial. Am J Clin Nutr 2010; 92: 723-732
41. Slavin JL, Jacobs D, Marquart L. Grain processing and nutrition. Crit Rev Food Sci Nutr 2000; 40: 309-326
42. Maki KC, Beiseigel JM, Jonnalagadda SS, Gugger CK, Reeves MS, Farmer MV et al. Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc 2010; 110: 205-214